The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)

被引：2

作者：

Albala, Bruce ^{[1
,14
,15
]}

Appelmans, Eline ^{[2
]}

Burress, Ramona ^{[3
,16
]}

De Santi, Susan ^{[1
,4
,17
]}

Devins, Theresa ^{[1
,18
]}

Klein, Gregory ^{[5
]}

Logovinsky, Veronika ^{[1
,19
]}

Novak, Gerald P. ^{[3
]}

Ribeiro, Kim ^{[6
]}

Schmidt, Mark E. ^{[7
]}

Schwarz, Adam J. ^{[8
]}

Scott, David ^{[9
]}

Shcherbinin, Sergey ^{[10
]}

Siemers, Eric ^{[11
]}

Travaglia, Alessio ^{[2
]}

Weber, Christopher J. ^{[12
]}

White, Leah ^{[2
,20
]}

Wolf-Rodda, Julie ^{[2
]}

Vasanthakumar, Aparna ^{[6
,13
]}

机构：

[1] Eisai Inc, Nutley, NJ USA

[2] Fdn Natl Inst Hlth, North Bethesda, MD USA

[3] Janssen Res & Dev LLC, Titusville, NJ USA

[4] Life Mol Imaging, Berlin, Germany

[5] F Hoffmann La Roche Ltd, Basel, Switzerland

[6] AbbVie Inc, N Chicago, IL USA

[7] Janssen Res & Dev, Beerse, Belgium

[8] Takeda Pharmaceut Co Ltd, Cambridge, MA USA

[9] Clario, San Mateo, CA USA

[10] Eli Lilly & Co, Indianapolis, IN USA

[11] Cogstate Ltd, New Haven, CT USA

[12] Alzheimers Assoc, Chicago, IL USA

[13] Abbvie, Genom Res Ctr, 1 N Waukegan Rd, N Chicago, IL 60064 USA

[14] Univ Calif Irvine, Program Publ Hlth, 856 Hlth Sci Quad, Irvine, CA 92697 USA

[15] Univ Calif Irvine, UCI Sch Med, Dept Neurol, 856 Hlth Sci Quad, Irvine, CA 92697 USA

[16] Takeda, 95 Hayden Ave, Lexington, MA 02421 USA

[17] Eisai Inc, Nutley, NJ USA

[18] Cognit Therapeut, 2500 Westchester Ave, Purchase, NY 10577 USA

[19] Lundbeck, 6 Pkwy N, Deerfield, IL 60015 USA

[20] Veranex, 5420 Wade Pk Blvd,Suite 204, Raleigh, NC 27607 USA

来源：

ALZHEIMERS & DEMENTIA | 2024年 / 20卷 / 01期

基金：

美国国家卫生研究院; 加拿大健康研究院;

关键词：

Alzheimer's disease clinical trials; Alzheimer's Disease Neuroimaging Initiative; biomarkers; neuroimaging; COGSTATE BRIEF BATTERY; FINANCIAL CAPACITY; DEMENTIA; MEMORY; BIOMARKERS; SCALE; ANK1; MCI;

D O I：

10.1002/alz.13483

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The Alzheimer's Disease Neuroimaging Initiative (ADNI) Private Partners Scientific Board (PPSB) encompasses members from industry, biotechnology, diagnostic, and non-profit organizations that have until recently been managed by the Foundation for the National Institutes of Health (FNIH) and provided financial and scientific support to ADNI programs. In this article, we review some of the major activities undertaken by the PPSB, focusing on those supporting the most recently completed National Institute on Aging grant, ADNI3, and the impact it has had on streamlining biomarker discovery and validation in Alzheimer's disease. We also provide a perspective on the gaps that may be filled with future PPSB activities as part of ADNI4 and beyond.

引用

页码：695 / 708

页数：14

共 50 条

[41] Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
Trojanowski, John Q.
Vandeerstichele, Hugo
Korecka, Magdalena
Clark, Christopher M.
Aisen, Paul S.
Petersen, Ronald C.
Blennow, Kaj
Soares, Holly
Simon, Adam
Lewczuk, Piotr
Dean, Robert
Siemers, Eric
Potter, William Z.
Weiner, Michael W.
Jack, Clifford R., Jr.
Jagust, William
Toga, Arthur W.
Lee, Virginia M. -Y.
Shaw, Leslie M.
ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 230 - 238
[42] A Focus on Structural Brain Imaging in the Alzheimer's Disease Neuroimaging Initiative
Braskie, Meredith N.
Thompson, Paul M.
BIOLOGICAL PSYCHIATRY, 2014, 75 (07) : 527 - 533
[43] Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative
Fowler, Mackenzie E.
Triebel, Kristen L.
Cutter, Gary R.
Schneider, Lon S.
Kennedy, Richard E.
JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (02) : 691 - 701
[44] Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative
Dunk, Michelle M.
Driscoll, Ira
JOURNAL OF ALZHEIMERS DISEASE, 2022, 85 (04) : 1519 - 1528
[45] Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
Veitch, Dallas P.
Weiner, Michael W.
Aisen, Paul S.
Beckett, Laurel A.
DeCarli, Charles
Green, Robert C.
Harvey, Danielle
Jack, Clifford R., Jr.
Jagust, William
Landau, Susan M.
Morris, John C.
Okonkwo, Ozioma
Perrin, Richard J.
Petersen, Ronald C.
Rivera-Mindt, Monica
Saykin, Andrew J.
Shaw, Leslie M.
Toga, Arthur W.
Tosun, Duygu
Trojanowski, John Q.
ALZHEIMERS & DEMENTIA, 2022, 18 (04) : 824 - 857
[46] Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants
Groechel, Renee C.
Tripodis, Yorghos
Alosco, Michael L.
Mez, Jesse
Qiu, Wei Qiao
Goldstein, Lee
Budson, Andrew E.
Kowall, Neil W.
Shaw, Leslie M.
Weiner, Michael
Jack, Clifford R., Jr.
Killiany, R. J.
NEUROBIOLOGY OF AGING, 2023, 131 : 144 - 152
[47] Biomarkers and phenotypic expression in Alzheimer's disease: exploring the contribution of frailty in the Alzheimer's Disease Neuroimaging Initiative
Canevelli, Marco
Arisi, Ivan
Bacigalupo, Ilaria
Arighi, Andrea
Galimberti, Daniela
Vanacore, Nicola
D'Onofrio, Mara
Cesari, Matteo
Bruno, Giuseppe
GEROSCIENCE, 2021, 43 (02) : 1039 - 1051
[48] Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
Gamberger D.
Ženko B.
Mitelpunkt A.
Shachar N.
Lavrač N.
Brain Informatics, 2016, 3 (3) : 169 - 179
[49] Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
Marco Canevelli
Ivan Arisi
Ilaria Bacigalupo
Andrea Arighi
Daniela Galimberti
Nicola Vanacore
Mara D’Onofrio
Matteo Cesari
Giuseppe Bruno
GeroScience, 2021, 43 : 1039 - 1051
[50] Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative
Weiner, Michael W.
Veitch, Dallas P.
ALZHEIMERS & DEMENTIA, 2015, 11 (07) : 730 - 733

← 1 2 3 4 5 →